Factors associated with referrals for directly observed treatment and unsuccessful treatment

医学 心理学
作者
Y.D. González Diaz,David Palma,H. Vargas-Leguás,Teresa Rodrigo,I. Molina-Pinargorte,Xavier Casas,Núria Forcada,Javier Santiago,Neus Altet,J.P. Millet
出处
期刊:International Journal of Tuberculosis and Lung Disease [International Union Against Tuberculosis and Lung Disease]
卷期号:28 (5): 237-242
标识
DOI:10.5588/ijtld.23.0396
摘要

OBJECTIVETo describe the characteristics of people indicated for directly observed treatment (DOT) in Spain, and the factors associated with unsuccessful treatment.METHODSThis was a multicentre observational study based on a prospective follow-up of patients over 18 years old diagnosed with TB between 2006 and 2019 from the registry of the Programa Integrado de Investigación en Tuberculosis (PII-TB). Sociodemographic and clinical variables were collected. Adjusted odds ratios (aORs) were calculated for the indication of DOT and for having an unsuccessful treatment.RESULTSA total of 7,883 patients were included. The indication of DOT was associated with being homeless (aOR 5.93, 95% CI 3.03-11.59), inactivity status (aOR 2.55, 95% CI 2.02-3.23), alcohol consumption (aOR 1.94, 95% CI 1.51-2.48), parenteral drug use (aOR 1.77, 95% CI 1.06-2.95) and HIV diagnosis (aOR 1.96, 95% CI 1.16-3.29). Unsuccessful treatment was associated with having an HIV diagnosis (aPR 2.31, 95% CI 1.31-4.08), having a worse clinical and radiological evolution (clinical progression: APR 15.59, 95% CI 8.21-29.60; radiological progression: aPR 12.84, 95% CI 6.46-25.52), need for hospitalisation (aPR 1.73, 95% CI 1.10-2.73), unsatisfactory tolerability (aPR 2.82, 95% CI 1.49-5.29), the existence of difficulties in understanding the prescribed treatment (aPR 1.92, 95% CI 1.21-3.06), as well as worse treatment satisfaction (aPR 7.27, 95% CI 4.32-12.24).CONCLUSIONThe prioritisation of vulnerable populations is a key aspect to carry out the new Global Plan to End TB 2023-2030. In these groups DOT indication should be increased to ensure adherence and patient follow-up and outcomes..

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热心路人应助beichuanheqi采纳,获得30
刚刚
terminal发布了新的文献求助10
刚刚
黄坤发布了新的文献求助10
刚刚
华仔应助承乐采纳,获得30
1秒前
年轻电源完成签到,获得积分10
1秒前
科研通AI2S应助代博士采纳,获得10
2秒前
热心乐驹完成签到,获得积分10
3秒前
3秒前
共享精神应助ZYH采纳,获得10
5秒前
gh完成签到,获得积分10
6秒前
Zyz发布了新的文献求助10
6秒前
充电宝应助lxp采纳,获得10
6秒前
陈嘻嘻完成签到 ,获得积分10
6秒前
我世界第一快应助元谷雪采纳,获得30
7秒前
7秒前
nyms发布了新的文献求助10
7秒前
承乐完成签到,获得积分10
8秒前
六沉完成签到 ,获得积分10
8秒前
李健的小迷弟应助曹沛岚采纳,获得10
9秒前
南风吹梦完成签到,获得积分10
9秒前
小二郎应助肖珂采纳,获得30
9秒前
10秒前
10秒前
Raymen完成签到,获得积分10
10秒前
11秒前
Scarlett发布了新的文献求助10
11秒前
第五明月完成签到,获得积分10
11秒前
Lucas应助sd采纳,获得10
12秒前
爱笑的语梦完成签到,获得积分10
12秒前
悦子完成签到,获得积分10
12秒前
烟花应助樂酉采纳,获得10
12秒前
藏山归发布了新的文献求助10
13秒前
13秒前
13秒前
科研通AI5应助lxdhs采纳,获得10
15秒前
承乐发布了新的文献求助30
15秒前
16秒前
Lay发布了新的文献求助10
17秒前
zpw123完成签到,获得积分20
17秒前
cqsjy完成签到,获得积分10
17秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
ALUMINUM STANDARDS AND DATA 500
Walter Gilbert: Selected Works 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3668047
求助须知:如何正确求助?哪些是违规求助? 3226494
关于积分的说明 9769640
捐赠科研通 2936459
什么是DOI,文献DOI怎么找? 1608519
邀请新用户注册赠送积分活动 759665
科研通“疑难数据库(出版商)”最低求助积分说明 735460